Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1001
PUT
Nucor
NUE
$54.3B
| $10.2M | 0.02% |
208,600
-41,700
| -17% | -$1.95M |
2013 Q2
1 quarter
|
|
1002
PUT
Whirlpool
WHR
$1.98B
| $10.2M | 0.02% |
69,800
+6,100
| +10% | +$807K |
2013 Q2
1 quarter
|
|
1003
G-III Apparel Group
GIII
$1.16B
| $10.2M | 0.02% |
373,606
+365,036
| +4,259% | +$9.29M |
2013 Q2
1 quarter
|
|
1004
CALL
Transocean
RIG
$5.77B
| $10.2M | 0.02% |
229,000
+73,300
| +47% | +$3.47M |
2013 Q2
1 quarter
|
|
1005
Synopsys
SNPS
$93.5B
| $10.2M | 0.02% |
269,832
+19,155
| +8% | +$710K |
2013 Q2
1 quarter
|
|
1006
PUT
Mercado Libre
MELI
$85.5B
| $10.2M | 0.02% |
75,300
+10,600
| +16% | +$1.27M |
2013 Q2
1 quarter
|
|
1007
CALL
Kimberly-Clark
KMB
$31.3B
| $10.1M | 0.02% |
112,331
-18,461
| -14% | -$1.71M |
2013 Q2
1 quarter
|
|
|
HR
1008
DELISTED
Healthcare Realty Trust Incorporated
HR
| $10.1M | 0.02% |
437,851
+274,922
| +169% | +$6.69M |
2013 Q2
1 quarter
|
|
1009
Crown Castle
CCI
$28.3B
| $10.1M | 0.02% |
138,300
+59,725
| +76% | +$4.27M |
2013 Q2
1 quarter
|
|
1010
CALL
Yum! Brands
YUM
$37.5B
| $10.1M | 0.02% |
196,687
-177,770
| -47% | -$9.22M |
2013 Q2
1 quarter
|
|
1011
CALL
Prudential Financial
PRU
$38.8B
| $10.1M | 0.02% |
129,100
-2,100
| -2% | -$165K |
2013 Q2
1 quarter
|
|
|
HERO
1012
DELISTED
HERCULES OFFSHORE INC COM STK
HERO
| $10.1M | 0.02% |
1,364,518
-1,377,497
| -50% | -$10M |
2013 Q2
1 quarter
|
|
|
ACH
1013
Accendra Health
ACH
$42.1M
| $10M | 0.02% |
289,936
-4,231
| -1% | -$148K |
2013 Q2
1 quarter
|
|
1014
PUT
Adobe
ADBE
$94.2B
| $10M | 0.02% |
192,500
+89,800
| +87% | +$4.28M |
2013 Q2
1 quarter
|
|
1015
Teva Pharmaceutical Industries Limited
TEVA
$46.3B
| $9.98M | 0.02% |
264,265
-194,404
| -42% | -$7.58M |
2013 Q2
1 quarter
|
|
|
BTU
1016
PUT
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
| $9.98M | 0.02% |
38,553
-18,387
| -32% | -$4.7M |
2013 Q2
1 quarter
|
|
1017
PUT
Elevance Health
ELV
$83.9B
| $9.97M | 0.02% |
119,300
+29,100
| +32% | +$2.49M |
2013 Q2
1 quarter
|
|
1018
Wells Fargo
WFC
$243B
| $9.97M | 0.02% |
241,248
+220,647
| +1,071% | +$9.42M |
2013 Q2
1 quarter
|
|
|
1019
CALL
Adobe
ADBE
$94.2B
| $9.95M | 0.02% |
191,500
+25,200
| +15% | +$1.2M |
2013 Q2
1 quarter
|
|
|
KATE
1020
DELISTED
Kate Spade & Company
KATE
| $9.92M | 0.02% |
394,785
-651,210
| -62% | -$15.9M |
2013 Q2
1 quarter
|
|
|
LO
1021
CALL
DELISTED
LORILLARD INC COM STK
LO
| $9.91M | 0.02% |
221,400
+17,800
| +9% | +$784K |
2013 Q2
1 quarter
|
|
1022
FMC
FMC
$1.33B
| $9.86M | 0.02% |
158,552
+156,216
| +6,687% | +$8.97M |
2013 Q2
1 quarter
|
|
1023
Puma Biotechnology
PBYI
$502M
| $9.86M | 0.02% |
183,674
-40,470
| -18% | -$2.18M |
2013 Q2
1 quarter
|
|
|
KRFT
1024
PUT
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $9.85M | 0.02% |
187,900
+88,900
| +90% | +$4.87M |
2013 Q2
1 quarter
|
|
|
CLR
1025
CALL
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $9.84M | 0.02% |
183,400
+75,200
| +70% | +$3.6M |
2013 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.